Dismissed
EB-2 NIW
EB-2 NIW Dismissed — Healthcare And Life Sciences (2022): the combined motion to reopen and reconsider was dismissed
Filing your own EB-2 NIW? See how your CV maps to the criteria this decision turned on — free strategy preview.
Decision Summary
The combined motion to reopen and reconsider was dismissed. The new evidence submitted by the petitioner, concerning a recent gene therapy project, could not be considered because it came into existence after the original petition was filed. Furthermore, the AAO determined that even if the evidence were considered, it would not establish the national importance of the petitioner's endeavor, as the work was for specific private clients and involved proprietary technology, rather than broadly benefiting the public or scientific community.
See how a decision like this gets cited in an EB-2 NIW petition →Criteria Discussed
Substantial Merit And National Importance Well Positioned To Advance The Proposed Endeavor Beneficial To The U.S. To Waive Job Offer
📄 Original decision (USCIS PDF)
Sign up free to download the original PDF
Downloaded the case? Use it in your next draft →Filing your own EB-2 NIW? Learn from this denial.
Upload your CV and see how your profile maps to the criteria the AAO flagged here — free strategy preview, no credit card.
Map Your CV to These Criteria →No credit card required.